K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 355 INR -1.4% Market Closed
Market Cap: 5.7B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+29%
Revenue
Forecast
-1%
Operating Income
Forecast
-15%
Net Income
Forecast
-11%

Wall Street
Price Targets

KILITCH Price Targets Summary
Kilitch Drugs (India) Ltd

Wall Street analysts forecast KILITCH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KILITCH is 475.32 INR with a low forecast of 470.66 INR and a high forecast of 489.3 INR.

KILITCH Lowest Forecast
Wall Street Target
470.66 INR
33% Upside
KILITCH Average Forecast
Wall Street Target
475.32 INR
34% Upside
KILITCH Highest Forecast
Wall Street Target
489.3 INR
38% Upside
Lowest
Price Target
470.66 INR
33% Upside
Average
Price Target
475.32 INR
34% Upside
Highest
Price Target
489.3 INR
38% Upside
Kilitch Drugs (India) Ltd Competitors:
Price Targets
600557
Jiangsu Kanion Pharmaceutical Co Ltd
42% Upside
RX
Biosyent Inc
10% Upside
STAR
Strides Pharma Science Ltd
119% Upside
N
4516
Nippon Shinyaku Co Ltd
20% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
42% Upside
RX
Biosyent Inc
10% Upside
STAR
Strides Pharma Science Ltd
119% Upside
N
4516
Nippon Shinyaku Co Ltd
20% Upside
CIPLA
Cipla Ltd
15% Upside
PBH
Prestige Consumer Healthcare Inc
8% Upside
M
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside
4536
Santen Pharmaceutical Co Ltd
45% Upside

Revenue
Forecast

Revenue Estimate
Kilitch Drugs (India) Ltd

For the last 8 years the compound annual growth rate for Kilitch Drugs (India) Ltd's revenue is 28%. The projected CAGR for the next 2 years is 39%.

28%
Past Growth
39%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Kilitch Drugs (India) Ltd

The compound annual growth rate of Kilitch Drugs (India) Ltd's operating income for the next 2 years is 43%.

N/A
Past Growth
43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Kilitch Drugs (India) Ltd

The compound annual growth rate of Kilitch Drugs (India) Ltd's net income for the next 2 years is 31%.

N/A
Past Growth
31%
Estimated Growth
Estimates Accuracy
22%
Average Beat
What are analyst estimates?

See Also

Summary
KILITCH intrinsic value, competitors valuation, and company profile.
DCF Valuation
KILITCH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KILITCH stock valuation using valuation multiples.
Wall Street Estimates
KILITCH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KILITCH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KILITCH's stock price target?
Price Target
475.32 INR

According to Wall Street analysts, the average 1-year price target for KILITCH is 475.32 INR with a low forecast of 470.66 INR and a high forecast of 489.3 INR.

What is Kilitch Drugs (India) Ltd's Revenue forecast?
Projected CAGR
39%

For the last 8 years the compound annual growth rate for Kilitch Drugs (India) Ltd's revenue is 28%. The projected CAGR for the next 2 years is 39%.

What is Kilitch Drugs (India) Ltd's Operating Income forecast?
Projected CAGR
43%

The compound annual growth rate of Kilitch Drugs (India) Ltd's operating income for the next 2 years is 43%.

What is Kilitch Drugs (India) Ltd's Net Income forecast?
Projected CAGR
31%

The compound annual growth rate of Kilitch Drugs (India) Ltd's net income for the next 2 years is 31%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 243,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.